Viewing Study NCT06054932


Ignite Creation Date: 2025-12-24 @ 9:45 PM
Ignite Modification Date: 2026-04-27 @ 2:37 PM
Study NCT ID: NCT06054932
Status: RECRUITING
Last Update Posted: 2023-09-26
First Post: 2023-08-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety, Tolerability, and Immunogenicity of LK101 Alone in Participants With Incurable Solid Tumors
Sponsor: Beijing Likang Life Science and Tech Co., Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
Keywords: